Back to News
Market Impact: 0.15
Biotech Stocks At 52-Week Highs - IOVA +31%, XERS, GRAL, ABCL, SGHT
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
Several biotech stocks reached 52-week highs on September 29, 2026, supported by catalysts including encouraging clinical-trial results or revised financial guidance. The report does not identify the companies, price moves, or specific clinical and financial developments, limiting its broader market significance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- September Ends on a Grim Market Note: Evening Briefing Americas
- Why is Lynas Rare Earths stock sliding today?
- Goldman Sachs pushes rate hike expectation to December
- Walgreens owner nears $9 billion deal to sell Boots chain- WSJ
- Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
- Kalshi, Polymarket trading volumes on some products raises questions amid massive growth